Image: (L-R) Assoc Prof Eric Yap from LKCMedicine, who is the Medical Director of the new lab, with co-founders of Pathnova Laboratories, Emeritus Professor Chan Soh Ha and Dr Ian Cheong. 

NTU Singapore and Pathnova Laboratories, a medical diagnostic company backed by Temasek Life Sciences Accelerator and headquartered in Temasek Life Sciences Laboratory, is contributing to Singapore’s COVID-19 diagnostic capability through its partnership in a new clinical diagnostic laboratory.

Amid the ongoing global COVID-19 situation, the lab plans to tap advanced technology like Artificial Intelligence (AI) and data analytics to innovate, boosting the country’s future pandemic response.

Situated at NTU Singapore’s Lee Kong Chian School of Medicine (LKCMedicine) Novena Campus, the NTU Clinical Diagnostic Laboratory was set up in April 2020 by a team of academic researchers, in support of the national effort to increase diagnostic testing capacity and commenced Covid-19 polymerase chain reaction (PCR) testing on 1 July 2020.

The partnership between NTU and Pathnova commenced on 1 March 2021, with Pathnova running the operations and NTU continuing to support and host the lab. Since then, the lab now known as Pathnova Laboratories @ LKCMedicine, has scaled up its operations and been engaged by the Singapore Ministry of Health in testing swabs from over 120,000 individuals, including routine rostered testing for residents of foreign worker dormitories.

Previous SMU Computing Dons Receive Global Recognition For Outstanding Contributions In Software Engineering And Artificial Intelligence
Next DBS Joins Leading Financial Consortium To Propose New Social, Environmental Impact-Reporting Rules For Banks

Suggested Posts

FairPrice Commits S$2 Million To Enhance Support For Local SMEs Through Business Development Amidst COVID-19

The Infinite Hotel Paradox

Accomodating Workers Affected By Lockdown In Malaysia

New NEA Facility To Boost Production Of Male Wolbachia-Aedes Aegypti Mosquitoes To Benefit More Residents